Clinical Trial Update: Monitoring of NOAC Therapy: Standardizing Reference Intervals

View source ↗

Summary

This completed clinical trial update reports on monitoring non-vitamin K antagonist oral anticoagulants (NOACs) and aims to standardize reference intervals to g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Eliquis (apixaban)
• Pradaxa (dabigatran etexilate)
• Savaysa (edoxaban)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Ischemic Stroke, Stroke, Acute | Status: COMPLETED